Your browser doesn't support javascript.
loading
Postdischarge pharmacist medication reconciliation: impact on readmission rates and financial savings.
Kilcup, Meg; Schultz, Diane; Carlson, Jim; Wilson, Bruce.
Afiliación
  • Kilcup M; Group Health Cooperative, Tukwila, WA 98168, USA. kilcup.m@ghc.org
J Am Pharm Assoc (2003) ; 53(1): 78-84, 2013.
Article en En | MEDLINE | ID: mdl-23636160
ABSTRACT

OBJECTIVE:

To assess the impact of ambulatory clinical pharmacist medication therapy assessment and reconciliation for patients postdischarge in terms of hospital readmission rates, financial savings, and medication discrepancies.

SETTING:

Group Health Cooperative (Group Health) in Washington State, from September 2009 through February 2010. PRACTICE DESCRIPTION Group Health is a nonprofit integrated group practice and health plan, operating 25 primary care medical centers and 5 specialty centers. Group Health's practice design is a patient-centered medical home model. PRACTICE INNOVATION All patients identified as high risk for readmission were followed by Group Health care management. Patients in care management who received a phone call from a pharmacist 3 to 7 days postdischarge for medication therapy assessment and reconciliation were identified as the medication review group (n = 243). Patients who did not receive clinical pharmacist intervention were included in the comparison group (n = 251). MAIN OUTCOME

MEASURES:

Readmission rates, financial savings, and medication discrepancies.

RESULTS:

Patients who received medication therapy assessment and reconciliation had decreased readmission rates at 7, 14, and 30 days postdischarge, with statistical significance at 7 and 14 days. Medication review versus comparison readmission rates were as follows 7 days 0.8% vs. 4% ( P = 0.01); 14 days 5% vs. 9% ( P = 0.04); and 30 days 12% vs. 14% ( P = 0.29). Financial savings for Group Health per 100 patients who received medication reconciliation was an estimated $35,000, translating to more than $1,500,000 in savings annually. Of patients, 80% had at least one medication discrepancy upon discharge.

CONCLUSION:

Most literature on medication reconciliation evaluates inpatient processes, whereas data on medication reconciliation postdischarge are limited. Our data support the hypothesis that medication assessment and reconciliation by pharmacists 3 to 7 days postdischarge can decrease readmissions and provide cost savings.
Asunto(s)

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Readmisión del Paciente / Farmacéuticos / Servicio de Farmacia en Hospital / Conciliación de Medicamentos Tipo de estudio: Health_economic_evaluation / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: J Am Pharm Assoc (2003) Año: 2013 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Readmisión del Paciente / Farmacéuticos / Servicio de Farmacia en Hospital / Conciliación de Medicamentos Tipo de estudio: Health_economic_evaluation / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: J Am Pharm Assoc (2003) Año: 2013 Tipo del documento: Article País de afiliación: Estados Unidos